Maximus delivered a steady first quarter, with revenue holding flat year over year and non-GAAP profits surpassing Wall Street forecasts. Management credited the results to operational efficiencies, particularly in the U.S. Federal Services segment, and successful implementation of automation in areas such as the No Surprises Act contract and Veterans Affairs case preparation. CEO Bruce Caswell highlighted that investments in artificial intelligence and process automation have begun to pay off, enabling the company to handle greater volumes and redirect staff to higher-value work.

Is now the time to buy MMS? Find out in our full research report (it’s free).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions Maximus’s Q1 Earnings Call

• Charlie Strauzer (CJS Securities) asked how the raised guidance accounted for the quarter’s strong performance and the outlook for the remainder of the year. CFO David Mutryn explained that guidance reflects Q2 results and remains cautious due to environmental risks.
• Charlie Strauzer (CJS Securities) inquired about the drivers behind the strong operating margin. CEO Bruce Caswell credited increased volumes and successful automation, particularly in enabling staff to focus on higher-value activities.
• Charlie Strauzer (CJS Securities) questioned the impact of increased federal scrutiny and whether procurement delays were affecting the pipeline. Caswell acknowledged delays in civilian agency contracts but noted healthy proposal activity and some benefit from contract extensions.
• Charlie Strauzer (CJS Securities) requested more detail on the performance of the Outside The U.S. segment. CFO David Mutryn highlighted improvements from restructuring and steady growth in the UK’s functional assessment services contract.
• Charlie Strauzer (CJS Securities) asked about the sustainability of the current business mix and pipeline. Management pointed to a balanced approach, with no reliance on new contract wins to achieve this year’s forecasts, but acknowledged uncertainty in future awards.

Catalysts in Upcoming Quarters

As we look to upcoming quarters, the StockStory team will be watching (1) whether automation and AI investments continue to drive operational efficiencies and margin improvement, (2) progress in securing new and rebid clinical assessment and federal contracts, and (3) the impact of ongoing government spending reviews on contract renewals and pricing. Developments in the company’s international business mix and federal procurement pipeline will also be critical signposts.

Maximus currently trades at $71.37, up from $67.22 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).

High-Quality Stocks for All Market Conditions

Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.

While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.